# Fulgent Genetics, Inc.: Form 8-K, filed May 5, 2023

- Company: [Fulgent Genetics, Inc.](/companies/flgt.md) (CIK 1674930)
- Form: 8-K
- Filed: 2023-05-05
- Accepted by EDGAR: May 5, 2023, 07:05 ET
- Period: 2023-05-05
- Accession: 0000950170-23-018076
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1674930/000095017023018076/flgt-20230505.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1674930/000095017023018076/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1674930/000095017023018076/flgt-20230505.htm

Filed May 5, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-018076. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.